Cargando…
Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis
Mucosal protective agents may improve healing of patients with endoscopic submucosal dissection-induced ulcers. The present study systematically evaluated published clinical trials to determine whether combined therapeutic use of mucosal protective agents and proton pump inhibitors can improve the o...
Autores principales: | Nishizawa, Toshihiro, Suzuki, Hidekazu, Kanai, Takanori, Yahagi, Naohisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345174/ https://www.ncbi.nlm.nih.gov/pubmed/25759512 http://dx.doi.org/10.3164/jcbn.14-101 |
Ejemplares similares
-
Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021) -
Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014) -
Endoscopic Submucosal Dissection in the Era of Proton Pump Inhibitors
por: Isomoto, Hajime, et al.
Publicado: (2009) -
Notice of Retraction: Rebamipide plus proton pump inhibitor versus proton
pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric
ulcer: a meta-analysis of randomized controlled trials
Publicado: (2014) -
Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)